ImageBiopsy Lab: First US Medical Device Approval for Austrian AI Company

VIENNA, AUSTRIA, November 20, 2019 / — ImageBiopsy Lab announces that in November 2019, the first AI (Artificial Intelligence)-based algorithm for radiology applications developed by an Austrian medical AI start-up has received FDA (510K) clearance. With this approval, the medical AI software KOALA (Knee Osteoarthritis Labelling Assistant) can now be commercially offered in the leading global healthcare market USA.

KOALA objectifies the common radiological parameters of knee osteoarthritis (OA). Of this protracted and debilitating disease, 70 million patients worldwide are affected. KOALA fully automatically assesses the radiological parameters that are critical for the diagnosis of OA and thus delivers an objective reading-support within seconds. The software blends seamlessly into the existing radiological environment, benefiting both medical staff and patients.

Already approved as a medical device in Europe, the software offers clinicians a number of significant simplifications in the diagnosis of this common bone and joint disease: consistent diagnostic accuracy and objectivity enable standardized and detailed radiological follow-ups. This is particularly important for the early detection and monitoring of the disease, which often progresses for decades.

CEO Richard Ljuhar regards this not only as an award for his company, but also as a great recognition for the entire Austrian start-up scene: "We are quite happy that an Austrian start-up is one of the first European companies to receive clearance for such complex AI-based software". Ljuhar would also like to thank the long-standing supporters, investors and the entire ImageBiopsy Lab Team.

Future market: USA
The current FDA-approved AI algorithms come mainly from industry leaders such as General Electric (GE) and Siemens Healthineers, as well as well-funded start-ups such as Zebra Medical and AiDoc (both Israel). ImageBiopsy Lab is currently ranked among the top 20 FDA approved algorithms in radiology worldwide and continues to position itself as a leader in musculoskeletal (MSK) radiology with one of the first approved AI algorithms in this discipline. With this FDA approval, the start for the market entry into the US has been made possible: the world's largest radiological conference (RSNA) will take place in early December 2019 in Chicago and is considered the official start for entry into the US. However, Ljuhar reiterates his intention to further expand our current headquarter in Vienna but to also focus on setting up a local subsidiary company in the US.

About ImageBiopsy Lab (November 2019)
ImageBiopsy Lab (IB Lab GmbH) was founded in 2016 as a spin-off of the medical technology company Braincon Technologies in Vienna. 16+ software engineers, physicians, and scientists are committed to fundamentally changing the processes, efficiency, and quality in radiology based on AI.

IB Lab is developing a novel, AI-supported modular software platform for a standardized and objective analysis of medical images. The modules of this technology platform identify/extract key radiological disease parameters that are critical for the prevention and treatment of various bone diseases. Using KOALA as an example, it is thus possible to provide a reliable support in reading knee X-ray, used by more than 50 sites worldwide every day. Additional modules for the hip and hand modules are also in use and will be submitted later this year for the FDA review. The vision to develop and certify a focused software platform for bone diseases also convinced well-known investors such as APEX Ventures and the AWS Gruenderfond, which have been on board since December 2018 as investors and fully support the further strategy of IB Lab.

Richard Ljuhar
ImageBiopsy Lab
+43 1 9051206
email us here
Visit us on social media:

Source: EIN Presswire


More in depth details now available about this unique product

Jetblack Corp. (OTCMKTS:JTBK)

CHICAGO, ILLINOIS, USA, November 20, 2019 / — Jetblack Corp. (OTC: JTBK) “The Company” “JTBK” reported more in depth details on their “first of its kind” wellness product in formulation. As a background, the recent identification of cannabinoid receptors, CB1 and CB2 receptors and their endogenous lipid ligands has started an exponential growth of studies exploring the endocannabinoid system and its regulatory functions concerning health and disease.

In the past decade, the endocannabinoid system has been implicated in a vast number of physiological functions, both in the central and peripheral nervous systems and in peripheral organs. More importantly, regulating the activity of the endocannabinoid system turned out to hold therapeutic promise in a vast range of disparate diseases and pathological conditions.

Jetblack Corp. has been formulating a product which helps flush or cleanse the endocannabinoid system and CB1 and CB2 receptors to make marijuana and its cannabinoids more effective. The more a person smokes or ingests marijuana, there becomes a diminishing rate of effectiveness compared to an individual who consumes cannabis less regularly. If an individual is a regular consumer of marijuana, the effects are much milder and less effective than someone who ingests less regularly. Often heavy users complain about never getting “high”, barely feeling anything, or needing concentrates to get the desired effects. At a certain point for the regular user, even the concentrates will have little effect. In comparison to a user who consumes cannabis less regularly, will feel much greater effects of the cannabis once consumed.

According to New Frontier Data. In 2017, statistics have shown roughly 12% of the adult population in the US consume marijuana daily, while 11% of the adult population uses it weekly. In 2018, overall sales of legal marijuana in the US was greater than 9 billion dollars.

JTBK’s product helps flush the endocannabinoid system and receptors so that a regular user can use less marijuana and be acutely more effective for the goals they would like to achieve. Potentially this will save the consumer money by using less marijuana products, have greater effectiveness for their desired effect, along with less unwanted side effects that marijuana gives by consuming less cannabis. A marijuana medical patient may also benefit greatly from this product by making the marijuana much more effective for relief of their conditions.

For someone that is looking to stop consuming cannabis for whatever reason, this product may also help to clear your system for “weening off” of the cannabis. Sometimes heavy users will have some unwanted side effects from suddenly stopping consumption. Some individuals may suffer a loss of appetite from suddenly stopping consumption. Along with, irritability and a restless sleep to name a few. Often a regular user who stops consumption for 2 weeks may still up to 500 nanograms or more in their system. Sometimes a regular user will need up to 60 days to clear their system completely. Our product may help clean out the system much faster, which will give less side effects to the individual in the “weening” process.

The endocannabiniod system is still being studied, and research is in its infancy. The company believes this product may also benefit non-cannabis users as well, as we know now the endocannabinoid system plays an important role in our health. “This is why we have stated this is a wellness product from the beginning. We look forward to put the final touches on the formulation, begin test trials, along with manufacturing and production.” explained the CEO of Jetblack Corp. Daniel A. Goldin.

More information about Jetblack Corp. can be found at its website: and its twitter handle @jetblackcorp

Information regarding investments or financing may be directed to
1-888-611-5825 by leaving a detailed message or by sending an email to:


This press release contains forward-looking statements. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward- looking statements can be identified by words such as "believe," "expect," "anticipate," "plan," "potential," "continue" or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties include market risks associated with our business, the inability to raise enough capital to complete our business, economic conditions and increasing competition. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The loss of key employees would be detrimental to the company success. Currently the company is considered a penny stock, which means the spreads can be very far apart, sometimes illiquid, and investors may not be able to sell when they want or for the price paid. In some circumstances the investor may lose all their investment.

Jetblack Corp
Emilia S. Olvera

Disseminated by:
DG Ventures, Inc.
IR Provider for Jetblack Corp.

Media Services
DG Ventures, Inc.
email us here
Visit us on social media:

Source: EIN Presswire

Justin Drach: Florida-based Attorney Fighting Widespread Abuses in the Psychiatric Industry

Nearly 150 CCHR supporters gathered for the Premiere Party of the Voices for Humanity Episode on Justin Drach at the Fort Harrison Grand Auditorium.

Nearly 150 CCHR supporters gathered for the Premiere Party of the Voices for Humanity Episode on Justin Drach at the Fort Harrison Grand Auditorium.

The headquarters for CCHR Florida are located in downtown Clearwater.

The headquarters for CCHR Florida are located in downtown Clearwater.

The Florida chapter of CCHR is a non-profit mental health watchdog dedicated to the protection of children.

The Florida chapter of CCHR is a non-profit mental health watchdog dedicated to the protection of children.

Justin Drach is a former Naval Aviator turned Florida-based attorney fighting widespread abuses of the psychiatric industry and the practice of illegally committing individuals, including children as young as two, into mental health institutions.

Justin Drach is a former Naval Aviator turned Florida-based attorney fighting widespread abuses of the psychiatric industry and the practice of illegally committing individuals, including children as young as two, into mental health institutions.

Justin Drach is a former Naval Aviator turned Florida-based attorney fighting widespread abuses of the psychiatric industry and the practice of illegally committing individuals, including children as young as two, into mental health institutions.

Justin Drach is a former Naval Aviator turned Florida-based attorney fighting widespread abuses of the psychiatric industry and the practice of illegally committing individuals, including children as young as two, into mental health institutions.

A new documentary features the work of attorney and mental health activist Justin Drach and his fight to protect human rights.

Florida is a target-rich environment for psychiatrists and corporations that are looking to squeeze profits from filled beds.”

— Diane Stein, President CCHR Florida

CLEARWATER, FLORIDA, UNITED STATES, November 20, 2019 / — Every year hundreds of thousands of people are taken into custody for involuntary psychiatric examination across the state of Florida. Called a Baker Act, the rampant abuse of rights under this law contributes to tens of millions of dollars in fraudulent billing. In a new documentary in “The Voices for Humanity” series on the Scientology TV network, attorney Justin Drach takes on the widespread illegal involuntary examination of men, women and children in Florida. Working directly with the Citizens Commission on Human Rights (CCHR), Justin Drach, a former Navy pilot, flies all over Florida seeking the safe release of countless individuals being held unjustly under the Baker Act.

“Today, in Florida, one of the greatest evils is fraudulent Baker Acts,” Drach states. “I make no bones about it, there is an epidemic of greed and abuse in medicine, especially the treatment of mental illness.”

Drach spent 10 years as a Naval aviator, including a tour of duty in Iraq. After military service, he earned his law degree and along with Amanda Thoele quickly established a prominent practice in Florida. His expertise—battling involuntary examination and potential involuntary commitment carried out by the psychiatric industry under the state’s infamous Baker Act. A strategic alliance with CCHR, a watchdog organization that exposes abuse in the mental health industry, has thrust Justin to the forefront of a movement fighting Baker Act violations. Through the specialized Baker Act Defense Attorney Symposium and Summit, known by the acronym BADASS, Drach helps to educate other attorneys in the art of securing freedom for Baker Act victims.

In support of Mr. Drach’s work, CCHR hosted an event on Wednesday 13 November at the historic Fort Harrison for the premiere of the documentary, “Wings of Justice” where the audience was appalled to learn of the horrific abuses perpetrated under the Baker Act and inspired to take action to help restore human rights.

According to Diane Stein, President of CCHR Florida, Florida is a target-rich environment for psychiatrists and corporations that are looking to squeeze profits from filled beds.

“Florida’s mental health act is weak and due process is virtually non-existent, said Stein. “Patients are bullied into submitting to ‘voluntary’ treatment all to avoid the bare minimum scrutiny of courts making people like Mr. Drach invaluable in the fight to end mental health human rights abuse in Florida.”

Ms. Stein, who is also featured on the Voices for Humanity series for her work in exposing unjust involuntary psychiatric examination of children and other mental health human rights abuses, encourages the friends and family of anyone who has suffered abuse in the mental health industry to submit a report at CCHR –

About CCHR: Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. L. Ron Hubbard, founder of Scientology, first brought psychiatric imprisonment to wide public notice: “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health,’” he wrote in March 1969.

Diane Stein
Citizens Commission on Human Rights of Florida
+1 727-422-8820
email us here
Visit us on social media:

Voices for Humanity: Justin Drach, Naval Aviator & Attorney (Trailor)

Source: EIN Presswire

ArangoDB Joins Cloud Native Computing Foundation

ArangoDB joins CNCF to continue its focus on providing a scalable native multi-model database

It is a natural choice for us to contribute to the Kubernetes and CNCF ecosystem which lets developers and their teams run even complex microservice architectures in a simpler way.”

— Claudius Weinberger, CEO and co-founder of ArangoDB

SAN FRANCISCO AND COLOGNE, USA AND GERMANY, November 20, 2019 / — ArangoDB and the Cloud Native Computing Foundation (CNCF) announced today, that the leading open-source multi-model database, ArangoDB, is now a member of the foundation behind some of the most popular open-source projects like Kubernetes (, Prometheus (, Fluentd ( or Rook (

By uniting graph, document, and key/value data models, along with a full-text search in one core and one query language, ArangoDB already gives developers flexibility and efficiency when building their applications. With integrations into modern orchestration systems like Kubernetes, ArangoDB continues to expands its simplicity mission to DevOps and DataOps.

Since 2015, ArangoDB committed itself to the era of modern orchestration systems and more efficient ways of deploying and running even complex applications. ArangoDB has been the first fully-certified database for Mesosphere (now D2iQ) and published one of the first Kubernetes operators including support for persistent volumes for allowing developers to run stateful applications on Kubernetes.

These early commitments also created the technical foundation to the recently released cloud service ArangoDB Oasis (, which uses Kubernetes and many other CNCF projects to allow managing hundreds of ArangoDB deployments on various cloud providers like GoogleCloud, AWS and Azure efficiently and securely.

“The whole idea of a native multi-model database is to provide a better way of creating applications” said Claudius Weinberger, CEO and co-founder of ArangoDB and added “It is a natural choice for us to contribute to the Kubernetes and CNCF ecosystem which lets developers and their teams run even complex microservice architectures in a simpler way. We are excited about the future of Kubernetes and to even better share our learnings, ideas and code with the community by joining the CNCF.”

Learn more:
– For more details about ArangoDB joining CNCF: Read the blog
– How Kubernetes is used in ArangoDBs managed service Oasis: Read the blog

About ArangoDB:
One database, one query language, and three data models. With more than 7 million downloads and over 8,000 stargazers on GitHub (, ArangoDB is the leading open source native multi-model database. It combines the power of graphs with JSON documents, a key-value store, and a full-text search engine, enabling developers to access and combine all of these data models with a single, elegant, declarative query language. Now also available as fully managed cloud service, ArangoDB Oasis (

Simplifying complexity and increasing productivity is the mission of ArangoDB Inc., the company behind the project. Founded in 2014, ArangoDB Inc. is a privately-held company backed by Bow Capital and Target Partners. It is headquartered in San Francisco and Cologne with offices and employees around the world. Learn more at

Jan Stücke
ArangoDB Inc.
+49 221 272299960
email us here

Source: EIN Presswire

Wearable Medical Devices Market Major Manufacturers, Trends, Demand, Share Analysis to 2025

New Market Study, Report "Wearable Medical Devices Market 2019 Global Market Demand, Opportunities, Growth Drivers, Challenges, Strategies and Forecasts 2025".

PUNE, MAHARASHTRA, INDIA, November 20, 2019 / — Wearable Medical Devices Market 2019-2025

New Market Study, Report "Wearable Medical Devices Market 2019 Global Market Demand, Opportunities, Growth Drivers, Challenges, Strategies and Forecasts 2025" Has been Added on

Report Summary:

Wearable Medical Devices Market to Witness an Upward Trend

This report provides in depth study of “Wearable Medical Devices Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Website Wearable Medical Devices Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

The wearable devices are becoming popular among the patients as well as doctors community around the globe. As the total populace is maturing and ceaseless maladies are on the ascent, the human services industry is quickly conveying innovative arrangements. The expansion of innovative therapeutic electronic gadgets and wearable hardware is incredibly improving patient results and decreasing social insurance costs. Associated patient demonstrating will be a basic factor in the proceeding with achievement of this field. The exponentially developing interest for associated medicinal gadgets is relied upon to arrive at 20 billion by 2020. There are many factors that drive the growth of the wearable device market in the world. The devices of remote patient monitoring and home health care are driving the growth of the wearable device market worldwide.

High pervasiveness way of life related issue, for example, diabetes and hypertension, requires consistent observing of a few physiological parameters, for example, glucose levels and circulatory strain, because of inactive way of life. This permits amalgamation of medicinal services information with convenient gadgets, which can be sent to doctors for ongoing access to information and insignificant mistakes. In addition, rising death rate due to non-transferable maladies is the significant concern requesting more spotlights on customized observing and care. Ultimately, this is expected to boost the demand further. There are several governments who are constantly making awareness campaign for people all around the globe. Growing pervasiveness of mortality rate along with chronic disease have become major concerns among government organizations as well as people across the world.

People nowadays are becoming aware about their health. The awareness of physical fitness has enabled the people in a large way. The people can track their fitness level by wearing fitness and medical devices. They can wear smart watches and smart band for tracking the fitness level. The wearable devices can be used as per the instruction of physicians and psychiatrist. The market of wearable devices has been grown leaps and bounds in key markets of the world. As per the market researcher, the market would achieve the double size of the present market

Request for Free Sample Report of “Wearable Medical Devices” Market @

Important key Players Analysis: Fitbit, Philips, Garmin, Omron, Drägerwerk, Nokia Technologies, Jawbone, Polar Electro, World Global Network [Wor(I)D], Activeinsights, Vitalconnect, Xiaomi, Misfit, Monica Healthcare and more.

Market Segmentation

The usage of the wearable device has become diverse and unique in every corner of the world. The market of wearable device has been segmented into three ways such as device type, segment type and application. The segment of the wearable device is segmented into four forms such as smart watches, activity monitors, patches and smart clothing. There are multiple types of wearable medical devices present in the market such as therapeutic devices and monitoring and diagnostic devices. The devices can be distributed through various channels such as hypermarkets, pharmacies and online. The device can be used in different application such as remote patient monitoring, home healthcare, and sports fitness and academies.

Geographical market classification

Let’s have a view over the international market. The USA, the UK, France, Germany, Canada, Mexico, Russia, China, India, Japan, Australia, New Zealand, South Africa, Egypt, Nigeria, Central and Latin America.

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@

Latest News

Many prominent companies that are creating advanced medical devices for meeting the needs of the patients worldwide.


+1 646-845-9349
email us here

Source: EIN Presswire

Global Patient Monitoring Systems Market Report 2019-2025 by Technology, Opportunities, Top Key Players and more…

A new market study, titled “Global Patient Monitoring Systems Market Professional Survey Report 2019”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, November 20, 2019 / — Patient Monitoring Systems Market

The global Patient Monitoring Systems market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Patient Monitoring Systems volume and value at global level, regional level and company level. From a global perspective, this report represents overall Patient Monitoring Systems market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Patient Monitoring Systems in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Patient Monitoring Systems manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abbott Laboratories
Roche Diagnostics
Siemens Healthcare
Ge Healthcare
Philips Healthcare
Nihon Kohden
Omron Corporation
Honeywell International
Bard Medical
Welch Allyn
Infinium Medical
Syncro Medical

Request Free Sample Report at

Segment by Regions
North America
Southeast Asia

Segment by Type
Hemodynamic Monitoring Systems
Neuromonitoring Systems
Cardiac Monitoring Systems
Fetal and Neonatal Monitoring Systems
Respiratory Monitoring Systems

Segment by Application

Table of Content:
1 Report Overview
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
5 United States
6 Europe
7 China
8 Japan
9 Southeast Asia
10 India
11 Central & South America
12 International Players Profiles
13 Market Forecast 2019-2025
14 Analyst's Viewpoints/Conclusions
15 Appendix

View Detailed Report at

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

+1 646-845-9349
email us here

Source: EIN Presswire

Hair Transplant Market 2014 Global Analysis, Size, Share, Growth, Trends & Forecast To 2026

Wiseguyreports.Com Adds “Hair Transplant– Global Market Share, Industry Analysis, Competitive Landscape, Strategies And Forecast To 2026”

PUNE, MAHARASTRA, INDIA, November 20, 2019 / — Hair Transplant Market 2014-2026

Report Overview:

A study on the global HAIR TRANSPLANT market reveals a detailed report about the progress, current state, and future forecast of the market. The objective of the market study is to define, segment, describe, and forecast the market as per various pre-defined categories. The report offers an overview of the competitive landscape of the HAIR TRANSPLANT market and profiles an extensive list of companies operating in the industry. The players are analyzed, shortlisted, and narrowed down in terms of their financial stability, revenue generation, product portfolio, and the various strategies employed to maintain or attain market growth.

Major Companies Covered:

The global HAIR TRANSPLANT market includes various leading players who are making consistent efforts to stand atop the market standings and lead the competitive rankings.

PhotoMedex Inc.
Hair Transplants of Florida
Hair Restoration Blackrock HRBR getFUE Hair Clinics Ltd.
Bernstein Medical
Lumenis Inc.
Solta Medical Inc.
L'Oreal SA
The Acibadem Hospitals Group
Allergan Plc.
ILHT Dubai
Limmer Hair Transplant Center
Restoration Robotics Inc.
The Hairline Clinic
Hair Transplant Center Turkey

Request Free Sample Report @

If you have any special requirements, please let us know and we will offer you the report as you want.

Market Dynamics:

The report even analyzes the core competencies of the profiled players and the percentage of share they are contributing to the overall market. This is done so as to gain an idea about the state of competition in the market. The report comprises study of the various competitive developments being made in the market like partnerships, collaborations and acquisitions, research and development activities, investments, product introductions, and so on. For the report to offer a comprehensive and acute data about the current and potential state of the market, a forecast period was ascertained. This was done by considering 2014 as the base year of the forecast period and 2026 as the end year. The primary goal of the report is to aid the stakeholders with insightful answers about the market for them to make precise and comparatively accurate investment decisions in the coming years.

Market Segmentation:

The segmentation of the global HAIR TRANSPLANT market is a key aspect of the study. The report effectively distributes the market as per different categories and segments and assesses the probable growth of each of the segments over the defined forecast period.

Regional Description:

A big part of the market segmentation includes the regional segmentation. The global HAIR TRANSPLANT market was geographically distributed across some of the leading regions around the world. The market was thoroughly analyzed and the potential growth was determined across each of these regions to enable a precise geographic understanding of the industry.

Research Methodology:

The methodology applied for the research of the global HAIR TRANSPLANT market comprised data capturing of the revenue that is being generated by the players operating in the market through a number of secondary sources.

Table of Contents:

1 Introduction

2 Key Findings of the Study

3 Market Dynamics

4 Value Chain of the Hair Transplant Market

5 Global Hair Transplant Market-Segmentation by Type

6 Global Hair Transplant Market-Segmentation by Application

7 Global Hair Transplant Market-Segmentation by Marketing Channel

8 Competitive Intelligence – Company Profiles

9 Global Hair Transplant Market-Segmentation by Geography


Enquiry Before Buying @

Wise Guy Reports
email us here

Source: EIN Presswire

Hair Transplantation Market Research Projection By Trends, Sales, Predicted Revenue, Outlook Analysis & Forecast To 2025

Hair Transplantation Market - 2019-2025

Hair Transplantation Market – 2019-2025

A new market study, titled “Discover Global Hair Transplantation Market By Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

PUNE, MAHARASHTRA, INDIA, November 20, 2019 / —

Hair Transplantation Market – 2019-2025

Market Overview

The global Hair Transplantation market is projected to grow significantly due to increasing hair related problems. Hair related problems are not restricted to any specific age and gender that have created a huge scope for this market to grow across the globe. This has created high a high demand for hair treatment and transplant in various regions that will boost the demand in the Hair Transplantation market.

Increasing consciousness for physical appearance among the people and rising disposable income may help the market to gain traction in the coming years. The global Hair Transplantation market classified on the basis of end-users and procedures. The procedure of hair treatment services is segmented into three major procedures that include follicular unit strip surgery, scalp reduction, and follicular unit extraction. Among these, follicular unit strip surgery is expected to lead the market and grow at a healthy CAGR during the forecast period.

The report also described the key parameters affecting the market growth in segmentation, regional analysis, and vendors landscape. The report elucidates how the global hair transplant service market is expected to grow in near future.

Get Sample Report PDF >>

The following manufacturers are covered:
Dermis Health Private Limited
Acibadem Hospitals Group
The Private Clinic
Bernstein Medical, P.C.
Advanced Hair Restoration
Limmer Hair Transplant Center
Bosley Inc.
Mosaic Clinic Hair Transplant Center

Global Hair Transplantation Market:

Trends and Opportunities Globally, the demand for hair transplant has increased as the number of people dealing with hair loss have grown largely. Approximately, 40% of women and 60% of men suffer from hair loss due to various reasons such as stress, illness, aging, or genetics. With the technological advancement introduced in Europe and North America that provides better Hair Transplantation are expected to expand this market. Moreover, with the introduction of robotics surgical hair transplant systems, such as ARTAS that will result in safe and efficient hair transplant procedure will also benefit the Hair Transplantation market. the growing use of neograft hair transplant systems that is done with the help of follicular unit extraction method, which can be used for both men and women is likely to fuel this market during the forecast period.

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases).

The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain. A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Browse Report »

Global Hair Transplantation Market:

Regional Analysis North America is leading the global Hair Transplantation market. The region is expected to rise at healthy CAGR during the forecast period between 2018 and 2026 with which the market valuation is projected to reach in billions by the end of 2026. Increasing hair loss problem between males and females in the U.S. is considered as the major driving factor for the growth of the market. Other factors such as stressful life, dandruff, smoking, and consumption of fast food will lead to an increase in hair loss problems, fueling the industry growth. On the other hand, Asia Pacific is also offering huge growth opportunities for the hair transplant service market due to poor nutrition and stress is considered as two major factors accountable for the growth in this region. With 51% of the population suffering from stress either because of work or because of other personal issues, India is estimated to lead the hair transplant service market in this region.

Global Hair Transplantation Market:

Companies Mentioned The global Hair Transplantation market marks the presence of leading players such as Medicamat, Hair Transplants of Florida, Hospitals Group, Bernstein Medical, P.C., Limmer Hair Transplant Center, and Bosley Inc. The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

Market segments and sub-segments
Market trends and dynamics Supply and demand
Market size Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis

Customization of the Report

Value chain analysis
Consumer behavior analysis at country level

The report includes six parts, dealing with:
1.) basic information;
2.) the Asia Hair Transplantation Speaker Market;
3.) the North American Hair Transplantation Speaker Market;
4.) the European Hair Transplantation Speaker Market;
5.) market entry and investment feasibility;
6.) the report conclusion.

Table of Content: Hair Transplantation

1 Study Coverage

2 Executive Summary

3 Breakdown Data by Manufacturers

4 Breakdown Data by Type

5 Breakdown Data by Application

11 Company Profiles

12 Future Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

14 Value Chain and Sales Channels Analysis

15 Research Findings and Conclusion

16 Appendix

Continued …

About Us:
“Wise Guy Reports Is Part of the Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data for Industries and Governments Around the Globe. Wise Guy Reports Features an Exhaustive List of Market Research Reports from Hundreds of Publishers Worldwide. We Boast a Database Spanning Virtually Every Market Category and an Even More Comprehensive Collection of Market Research Reports Under These Categories and Sub-Categories”.


Partner Relations & Marketing Manager



Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Wise Guy Reports
email us here

Source: EIN Presswire

RNA Therapeutics 2020 to Highlight Developments in Delivery Mechanisms

RNA Therapeutics 2020

RNA Therapeutics 2020

SMi Reports: Delivery Mechanisms will be a key focus of the RNA Therapeutics conference taking place in London on 18th – 20th February 2020.

LONDON, UNITED KINGDOM, November 20, 2019 / — SMi’s 11th annual RNA Therapeutics conference will take place in London on 18th – 20th February. This year’s event will explore the latest discoveries in oligonucleotide-based therapeutics, novel mRNA technology, immunotherapy and vaccines. Developments in delivery mechanism technologies will feature as a key topic.

Register by 29th November to save £200 at:

Researchers have seen promising results related to major challenges in the field of delivery mechanisms. RNA Therapeutics 2020 will feature expert presentations related to overcoming these challenges, including, intracellular delivery, stability and immune response activation.

Presentations Highlighting Delivery Mechanisms include:

Optimising Nanoparticle Mediated Delivery of siRNAs to Treat Cancer and Fibrosis
– David Evans, CSO, Sirnaomics, Inc

Design of Safe and Potent Nucleic Acid Therapeutics
– Pete Lutwyche, CTO, Genevant Sciences

Overcoming Lung Barriers to siRNA Delivery in Cystic Fibrosis through Tailored Lipid/Polymer Hybrid Nanaparticles
-Francesca Ungaro, Associate Professor, University Of Napoli Federico Ii

Aiming at Delivering RNA to Tumours Using Intra-Venous Injections
– Steve Pascolo, Founder and CEO, Miescher Pharma

RNA Therapeutics 2020 will feature presentations by more than 18 industry leaders. In addition to delivery technologies, experts will cover topics, such as, clinical translation, applications of RNA-based drugs for modulation of gene and protein expression and genome editing.

Download the event brochure from

RNA Therapeutics
Focus Day: 18th February 2020
Conference: 19th – 20th February 2020
Copthorne Tara Hotel, London, UK

Proudly sponsored by:
ChemGenes | Thermo Fisher Scientific

— ENDS –
Contact Information:
For media enquiries contact Alia Malick on +44 (0)20 7827 6168
For all delegate enquiries, contact Hakam Panum on +44 (0)20 7827 6128

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

Neill Howard
SMi Group Ltd
+44 2078276000
email us here

Source: EIN Presswire

Glucosamine Market: Size, Share and Global Opportunity Analysis Outlook to 2024

Global Glucosamine Market Trends, Forecast, And Opportunity Assessment (2019-2024)

PUNE, MAHARASHTRA, INDIA, November 20, 2019 / — Glucosamine Industry


Glucosamine can be referred to as an amino acid, which can be naturally found in the cartilage of the joints. It is also considered as a precursor in the biochemical synthesis of glycosylated lipids and proteins. Glucosamine supplements possess anti-aging and anti-inflammatory properties, which helps to enhance gut health, digestion, and also treat inflammatory bowel disease.

Glucosamine supplements are thus consumed by people suffering from joint and bone pain as well as temporo-manibular joint (TMJ) disorder. They are also extensively used in cosmetic products as it helps in the formation of connective tissues and also promotes hydration and exfoliation.

With the rising number of geriatric population across the globe, coupled with disorders associated with joints and bones like arthritis and osteoarthritis, the glucosamine market is gaining significant prominence globally. The surging need for glucosamine supplements in order to promote healthy growth of hair and skin will create new growth opportunities for the market over the forecast period.

The rising number of vegan consumers, especially in developed regions like the U.S. is predicted to be another driving factor for the glucosamine market. Moreover, the ever-increasing population, robust growth in the healthcare industry, and consumer awareness associated with joint and bone health are some of the major factors likely to bolster the market growth in the coming years. Additionally, favorable regulatory framework regarding product utilization in the manufacturing of F&B is predicted to augment the market growth in the coming few years.

On the contrary, the dearth of awareness among people associated with the benefits of glucosamine supplements along with the presence of substitutes such as, collagens, omega 3 fatty acids, and fish oils, and herbal ingredients are anticipated to restrict the market growth during the assessment period.

Request for Sample Report @

Key Players

Golden-Shell Pharmaceutical
Aoxing Biotechnology
Yangzhou Rixing Bio-Tech
Nanjing Health Herb Bio-Tech
Shinfuda Marine Biotechnology
Fengrun Biochemical
Jiangsu Jiushoutang
Dongcheng Biochemical
Chengyi Pharmaceutical
KOYO Chemical
Bayir Chemicals
Panvo Organics
Wellable Marine Biotech

Segmental Analysis

The global glucosamine market has been segmented on the basis of type and application.

By type, the glucosamine market is segmented into Glucosamine Sulfate Potassium Chloride, Glucosamine Hydrochloride, N-acetylglucosamine, and Glucosamine Sulfate Sodium Chloride.

The application segment comprises medicine, health food, cosmetics, and others. Of these, the medicine sector will gain significant prominence, mainly due to the booming pharmaceutical industry worldwide. Glucosamine is extensively used in the production of medicines, which is likely to contribute to the market growth in the coming years.

Regional Insights

Geographically, the glucosamine market spans across South America, Asia Pacific, Europe, North America, and the Middle East & Africa.

Considering the global scenario, the glucosamine market is prominent among the European region as a prescription or over-the-counter medication. The product is either reimbursed or subsidized by insurers or government health plans. The glucosamine market finds significance in the countries of Europe due to the prevailing trend of osteoarthritis. The product finds recommendations for treating osteoarthritis in European countries as well as in countries such as, Australia, the U.S., and Canada.

Surging consumption of sports nutrition in Thailand, along with weight management products in South Korea and China is anticipated to create growth opportunities for the glucosamine market during the estimated timeframe. The rising need for functional F&B is anticipated to augment the business scenario in the coming years.

Leave a Query @

Table of Contents

1 Industry Overview

2 Industry Environment (PEST Analysis)

3 Glucosamine Market by Type

4 Major Companies List
4.Glucosamine Cargill (Company Profile, Sales Data etc.)
4.2 KOYO Chemical (Company Profile, Sales Data etc.)
4.3 YSK (Company Profile, Sales Data etc.)
4.4 AMPIL (Company Profile, Sales Data etc.)
4.5 Bayir Chemicals (Company Profile, Sales Data etc.)
4.6 Panvo Organics (Company Profile, Sales Data etc.)
4.7 TSI (Company Profile, Sales Data etc.)
4.8 Wanbury (Company Profile, Sales Data etc.)
4.9 Wellable Marine Biotech (Company Profile, Sales Data etc.)
4.10 Golden-Shell Pharmaceutical (Company Profile, Sales Data etc.)
4.11 Aoxing Biotechnology (Company Profile, Sales Data etc.)
4.12 Yangzhou Rixing Bio-Tech (Company Profile, Sales Data etc.)
4.13 Fengrun Biochemical (Company Profile, Sales Data etc.)
4.14 Jiangsu Jiushoutang (Company Profile, Sales Data etc.)
4.15 Dongcheng Biochemical (Company Profile, Sales Data etc.)
4.16 Chengyi Pharmaceutical (Company Profile, Sales Data etc.)
4.17 Nanjing Health Herb Bio-Tech (Company Profile, Sales Data etc.)
4.18 Shinfuda Marine Biotechnology (Company Profile, Sales Data etc.)

5 Market Competition

6 Demand by End Market

7 Region Operation

8 Marketing & Price

9 Research Conclusion

Buy Now @


Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

email us here

Source: EIN Presswire